ESTANasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
ESTABLISHMENT LABS HOLDINGS INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$58.26−0.92 (-1.55%)
Close on Oct 19, 2026
- Market cap
- $1.75B
- P/E (TTM)
- –
- Dividend yield
- –
ESTABLISHMENT LABS HOLDINGS INC. revenue by segment
By business segment
By product or service
By region
| Revenue | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | TTM Q2 23 | TTM Q1 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMEA (Europe / Middle East / Africa) | $91.05M | $81.62M | $82.02M | $79.00M | $78.21M | $77.77M | $81.54M | $80.77M | $80.15M | $79.90M | $68.69M | $64.49M | 43.1% | +16.4% |
| North America | $45.56M | $32.13M | $20.57M | $10.44M | $4.41M | $1.05M | $914.00K | – | $2.16M | – | – | – | 21.6% | +933.0% |
| Latin America | $39.93M | $36.20M | $34.13M | $33.53M | $35.00M | $34.74M | $37.75M | $45.18M | $48.89M | $54.27M | $54.01M | $51.88M | 18.9% | +14.1% |
| Asia-Pacific | $34.54M | $41.03M | $40.70M | $47.26M | $48.41M | $39.50M | $31.15M | $28.53M | $33.95M | $41.46M | $52.56M | $51.82M | 16.4% | -28.6% |
| Other | – | – | – | – | – | – | $914.00K | $1.32M | $2.16M | $1.78M | $1.89M | $1.59M | – | – |
From the segment and revenue-disaggregation notes of Establishment Labs's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.